HAVCR1 and diabetic kidney disease: Kapoula et al. (56) provide additional data about the role of two biomarkers, KIM-1 and YKL-40, in the development of early diabetic nephropathy, with both being promising biomarkers in the diagnosis of the disease as they can be detectable in early stages and subclinical diseases.